Alphabet Inc. - Q1 2022 holdings

$3.08 Billion is the total value of Alphabet Inc.'s 70 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 6.9% .

 Value Shares↓ Weighting
DXCM BuyDexcom Inc$537,484,000
+42.2%
1,050,595
+49.2%
17.44%
+91.0%
PATH  UiPath Inccl a$303,742,000
-49.9%
14,068,6740.0%9.86%
-32.7%
 IonQ Inc$279,534,000
-23.6%
21,907,0380.0%9.07%
+2.7%
VERV  Verve Therapeutics Inc$250,427,000
-38.1%
10,974,0110.0%8.12%
-16.8%
OSCR  Oscar Health Inccl a$239,706,000
+27.0%
24,042,8640.0%7.78%
+70.7%
LYFT  Lyft Inc$235,705,000
-10.1%
6,138,1540.0%7.65%
+20.8%
 EQRX Inc$196,393,000
-39.4%
47,552,6870.0%6.37%
-18.6%
 Planet Labs PBC$162,269,000
-17.4%
31,942,6410.0%5.26%
+11.0%
SNOW NewSnowflake Inccl a$122,723,000535,604
+100.0%
3.98%
RCUS  Arcus Biosciences Inc$80,902,000
-22.0%
2,563,4410.0%2.62%
+4.8%
 Freshworks Inc$72,318,000
-31.8%
4,035,5950.0%2.35%
-8.3%
 Robinhood Mkts Inc$66,585,000
-23.9%
4,928,5350.0%2.16%
+2.2%
DM  Desktop Metal Inc$52,371,000
-4.2%
11,048,7300.0%1.70%
+28.6%
BuyBenson Hill Inc$49,588,000
-53.9%
15,352,271
+4.1%
1.61%
-38.0%
RLAY BuyRelay Therapeutics Inc$46,953,000
-2.3%
1,568,753
+0.3%
1.52%
+31.3%
SellToast Inccl a$31,132,000
-90.6%
1,432,660
-84.9%
1.01%
-87.3%
LYEL  Lyell Immunopharma Inc$29,619,000
-34.8%
5,865,1250.0%0.96%
-12.3%
 Adagio Therapeutics Inc$25,904,000
-37.2%
5,680,7850.0%0.84%
-15.7%
ME  23andMe Holding Co$25,802,000
-42.5%
6,736,7850.0%0.84%
-22.7%
SANA  Sana Biotechnology Inc$23,231,000
-46.6%
2,812,5000.0%0.75%
-28.3%
GLUE  Monte Rosa Therapeutics Inc$20,525,000
-31.3%
1,464,0150.0%0.67%
-7.8%
ILMN  Illumina Inc$18,682,000
-8.2%
53,4700.0%0.61%
+23.4%
BEAM  Beam Therapeutics Inc$18,428,000
-28.1%
321,6040.0%0.60%
-3.4%
 Science 37 Holdings Inc$17,340,000
-57.1%
3,241,0750.0%0.56%
-42.3%
 Enjoy Technology Inc$16,512,000
-17.8%
4,345,3400.0%0.54%
+10.5%
 Duolingo Inc.$13,738,000
-10.4%
144,4440.0%0.45%
+20.5%
RAPT SellRAPT Therapeutics Inc$11,881,000
-48.5%
540,270
-13.9%
0.38%
-30.9%
 Tenaya Therapeutics Inc$10,787,000
-37.8%
915,7050.0%0.35%
-16.5%
KRON  Kronos Bio Inc$10,398,000
-46.8%
1,438,2320.0%0.34%
-28.6%
MGTA  Magenta Therapeutics Inc$9,684,000
-34.5%
3,339,1380.0%0.31%
-12.0%
NewRani Therapeutics Hldgs Inc$9,645,000714,471
+100.0%
0.31%
IDYA  Ideaya Biosciences Inc$8,428,000
-52.7%
753,1870.0%0.27%
-36.5%
VACC SellVaccitech PLCads$7,871,000
-58.4%
1,513,644
-11.2%
0.26%
-44.2%
SPRO  Spero Therapeutics Inc$7,743,000
-45.7%
889,9790.0%0.25%
-27.0%
FHTX  Foghorn Therapeutics Inc$7,629,000
-33.4%
500,9010.0%0.25%
-10.5%
VERA SellVera Therapeutics Inccl a$7,084,000
-62.9%
301,580
-57.7%
0.23%
-50.0%
NEWR  New Relic Inc$6,095,000
-39.2%
91,1320.0%0.20%
-18.2%
FULC  Fulcrum Therapeutics Inc$6,041,000
+33.7%
255,4520.0%0.20%
+79.8%
DBTX  Decibel Therapeutics Inc$4,974,000
-34.6%
1,636,2580.0%0.16%
-12.5%
TSHA  Taysha Gene Therapies Inc$4,179,000
-44.0%
640,8820.0%0.14%
-24.4%
OMIC  Singular Genomics Systems Inc$3,701,000
-45.4%
586,5840.0%0.12%
-26.8%
EVLO  Evelo Biosciences Inc$3,595,000
-44.2%
1,060,4950.0%0.12%
-24.5%
 Amplitude Inc$3,492,000
-65.2%
189,4470.0%0.11%
-53.3%
 Hyperfine Inc$3,181,000
-51.2%
898,7200.0%0.10%
-34.4%
 Tscan Therapeutics Inc$3,016,000
-37.8%
1,077,0800.0%0.10%
-16.2%
AUTL  Autolus Therapeutics PLCspon adr$2,912,000
-19.6%
698,2620.0%0.09%
+6.8%
ALEC  Alector Inc$2,506,000
-31.0%
175,8660.0%0.08%
-8.0%
NVTA  Invitae Corp$1,723,000
-47.8%
215,9650.0%0.06%
-30.0%
EXAS  Exact Sciences Corp$1,622,000
-10.2%
23,2050.0%0.05%
+20.5%
OPRT  Oportun Finl Corp$1,361,000
-29.1%
94,7880.0%0.04%
-4.3%
CRTX  Cortexyme Inc$1,169,000
-51.0%
189,1220.0%0.04%
-34.5%
S SellSentinelone Inccl a$822,000
-88.2%
21,231
-84.7%
0.03%
-84.0%
TWLO SellTwilio Inccl a$611,000
-38.5%
3,710
-1.7%
0.02%
-16.7%
 Nextdoor Holdings Inc$583,000
-24.1%
97,3910.0%0.02%0.0%
SQZ  SQZ Biotechnologies Co$500,000
-46.1%
103,9290.0%0.02%
-27.3%
 WeWork Inccl a$434,000
-20.7%
63,6450.0%0.01%
+7.7%
CMPX  Compass Therapeutics Inc$264,000
-56.8%
192,7940.0%0.01%
-40.0%
SPGI  S&P Global Inc$243,000
-12.9%
5920.0%0.01%
+14.3%
NewCue Health Inc$174,00027,000
+100.0%
0.01%
RGEN  Repligen Corp$72,000
-28.7%
3830.0%0.00%0.0%
UBER ExitUber Technologies Inc$0-49,466
-100.0%
-0.05%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPERO THERAPEUTICS INC24Q3 20233.5%
AUTOLUS THERAPEUTICS PLC22Q3 20232.8%
Magenta Therapeutics Inc.21Q2 20233.8%
DEXCOM INC20Q3 202317.4%
Evelo Biosciences Inc.20Q1 20231.6%
ALECTOR INC19Q3 20231.1%
Lyft Inc18Q2 202351.9%
QUINCE THERAPEUTICS INC18Q3 20230.6%
Arcus Biosciences Inc17Q1 202212.7%
FULCRUM THERAPEUTICS INC17Q3 20230.7%

View Alphabet Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Alphabet Inc. Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ARRIS International plcFebruary 14, 20197,603,5004.4%

View Alphabet Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
1442024-03-28
1442024-03-27
42024-03-26
42024-03-26
42024-03-26
42024-03-26
42024-03-26
42024-03-26
1442024-03-20
1442024-03-20

View Alphabet Inc.'s complete filings history.

Compare quarters

Export Alphabet Inc.'s holdings